http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102020007494-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db9b1dc7965e1a582a4f0917be5defb2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-58 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-191 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-72 |
| filingDate | 2020-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74baca4a51d03b79a25f9ff135ea781a |
| publicationDate | 2022-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-102020007494-A1 |
| titleOfInvention | Anti-inflammatory oxylipins |
| abstract | The object of the present invention was to provide new compounds with anti-inflammatory properties which are stable, simple and inexpensive to produce. They could be used as new pharmaceutical agents in inflammation-associated diseases. According to the invention, this object is achieved by a compound of the formula (I) solved. The meaning of the individual elements can be found in the description and the patent claims. A preferred embodiment of the connection according to the invention is where R 1 is a hydroxy, alkoxy, aryloxy, amino, alkylamino, dialkylamino or arylamino group and R 2 , R 3 and R 4 are independently hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl, acyl (e.g. alkoxyacyl, aminoacyl) , aminocarbonyl, alkoxycarbonyl or silyl groups. |
| priorityDate | 2020-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 80.